U.S. pharma giant copyright scrapped two experimental weight loss pills very last 12 months—a after-each day tablet, lotiglipron, because of elevated liver enzymes along with a twice-each day pill, danuglipron, because of solid Uncomfortable side effects—but CEO Albert Bourla has sai